Search

everythinglearnresearchcommunity

for

Search:↓

Shorter, thinner hairs indicate AGA, while longer, thicker hairs suggest CTE; counting and measuring shed hairs helps diagnose hair loss type.

Different patterns on the scalp help diagnose types of hair loss without needing a biopsy.

Most older adults experience pattern hair loss due to shrinking hair follicles, with men and women showing different balding patterns.

Hair density and thickness decrease in specific scalp areas in people with androgenetic alopecia.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Alopecia areata significantly worsens quality of life, suggesting a need for mental health support.

1% anthralin ointment is effective and safe for treating severe alopecia areata in children.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Janus kinase inhibitors are effective and safe for treating Alopecia Areata.

Ritlecitinib is safe and may effectively treat alopecia areata.

The fractional carbon dioxide laser is a safe and effective treatment for alopecia areata and works better than betamethasone valerate cream alone.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Cryotherapy and steroid injections are similarly effective and safe for treating alopecia areata.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Alopecia areata treatments often don't lead to lasting improvement.

Baricitinib stops hair loss and promotes regrowth in alopecia areata.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Alopecia areata may be linked to higher heart disease risk.

Mesenchymal Stem Cell Conditioned Media can significantly regrow hair in alopecia areata patients.

Topical methotrexate is more effective and as safe as betamethasone for treating alopecia areata.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Continued baricitinib treatment leads to significant scalp hair regrowth in severe alopecia areata patients.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Reducing the dose of Baricitinib to 2mg led to a loss of hair regrowth benefits in nearly half of the patients by Week-104.

New treatments for alopecia areata show promise, but standardized guidelines are needed.